Krystal Biotech, Inc. (FRA:4KB)
Germany · Delayed Price · Currency is EUR 185.10
-2.55 (-1.36%)
Last updated: Nov 28, 2025, 6:40 PM CET
Krystal Biotech Market Cap
Krystal Biotech has a market cap or net worth of €5.45 billion as of December 1, 2025. Its market cap has increased by 8.81% in one year.
Market Cap
5.45B
Enterprise Value
4.71B
Revenue
318.05M
Ranking
n/a
PE Ratio
32.16
Stock Price
€185.10
Market Cap Chart
Since September 20, 2017, Krystal Biotech's market cap has increased from 85.56M to 5.45B, an increase of 6,271.58%. That is a compound annual growth rate of 65.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 1, 2025 | 5.37B | 23.29% |
| Dec 31, 2024 | 4.35B | 37.47% |
| Dec 29, 2023 | 3.17B | 65.87% |
| Dec 30, 2022 | 1.91B | 24.59% |
| Dec 31, 2021 | 1.53B | 58.47% |
| Dec 31, 2020 | 966.66M | 13.17% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Sep 20, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 242.88B |
| Siemens Aktiengesellschaft | 176.79B |
| Allianz SE | 141.56B |
| Deutsche Telekom AG | 132.19B |
| Siemens Energy AG | 98.23B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 69.85B |
| Rheinmetall AG | 67.93B |
| Deutsche Bank Aktiengesellschaft | 58.37B |